Medtech Convergence Fund
Overview
The Medtech Convergence Fund (MCF) is a seed and early-stage venture capital fund committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies. Our fund strategy is focused on the increasing convergence of medical technology with software, telecommunications, and new service models to create solutions to some of the most significant health challenges. MCF's mission is to invest in therapeutic and monitoring technologies that offer superior patient outcomes while enabling better healthcare efficiency.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanopath | Aug 2022 | Series A | Lead |
| Podimetrics | Mar 2022 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Gregory Madden
Member Board Of Directors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Medtech Convergence Fund based?
Medtech Convergence Fund is headquartered in Boston, Massachusetts, United States.
When was Medtech Convergence Fund founded?
Medtech Convergence Fund was founded in 2020.
How many portfolio companies does Medtech Convergence Fund have?
Medtech Convergence Fund has 3 portfolio companies in Caplight's dataset.
What are some companies in Medtech Convergence Fund's portfolio?
Recent investments visible on Caplight include Nanopath, Podimetrics.
What was Medtech Convergence Fund's most recent investment?
Medtech Convergence Fund's most recent investment on Caplight was in Nanopath in 2022.
What sectors does Medtech Convergence Fund focus on?
Medtech Convergence Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Medtech Convergence Fund focus on?
Medtech Convergence Fund typically invests at the Early stage.